Ergoferon clinical trials
How each study uses ergoferon is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Ergoferon
- 7
Studies by the year they started
7 studies that test it; most in 2016 (2)
| Year | Studies |
|---|---|
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 7 · Other 0
Studies
Open first, then newest update. How each study uses ergoferon is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 7
- Efficacy and Safety of Ergoferon for COVID-19 Prevention During Vaccination Against SARS-CoV-2CompletedPhase 3Materia Medica HoldingNCT05069649Written as Ergoferon
- Clinical Trial of Efficacy and Safety of Ergoferon in the Treatment of Acute Respiratory Viral Infections in ChildrenCompletedPhase 4Materia Medica HoldingNCT03039621Written as Ergoferon
- Clinical Trial of Safety and Efficacy of Ergoferon in Liquid Dosage Form in Treatment of Acute Upper Respiratory Tract Infections in AdultsCompletedPhase 3Materia Medica HoldingNCT01765920Written as Ergoferon
- Clinical Trial of Efficacy and Safety of Ergoferon in the Treatment of Viral Intestinal Infections in ChildrenCompletedPhase 4Materia Medica HoldingNCT03039699Written as Ergoferon
- Comparative Clinical Trial of Efficacy and Safety of Ergoferon Versus Oseltamivir in Treatment of InfluenzaCompletedPhase 4Materia Medica HoldingNCT01850446Written as Ergoferon
- Clinical Trial of Safety and Clinical Efficacy of Ergoferon in Liquid Dosage Form in Treatment of Acute Upper Respiratory Tract Infections in ChildrenCompletedPhase 3Materia Medica HoldingNCT01843842Written as Ergoferon
- Clinical Trial of Clinical Efficiency and Safety of Ergoferon in Treatment of InfluenzaCompletedPhase 4Materia Medica HoldingNCT01804946Written as Ergoferon